V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330002183 | 330001226 | 1.83 | null | Adjuvant (A) | 2014-04-14 | 2014-04-14 | Cisplatin | 02 | Y | 330008182 | CISPLATIN |
| 330002184 | 330001227 | null | 66 | Curative (C) | 2015-05-22 | 2015-05-22 | CNS LGG2004 03 vinc + carbo | 02 | null | 330008185 | NOT MATCHED |
| 330002185 | 330001228 | 1.6 | 58 | Curative (C) | 2015-03-12 | 2015-04-02 | Cisplatin 7 day | N | Y | 330008188 | CISPLATIN |
| 330002186 | 330001229 | 0 | null | Curative (C) | 2016-03-28 | 2016-03-28 | NB HRNBL-1 COJEC Ind COURSE A | Y | N | 330008190 | NOT MATCHED |
| 330002187 | 330001229 | 1.56 | 18 | Curative (C) | 2016-02-15 | 2016-02-20 | Cisplatin | N | null | 330008190 | CISPLATIN |
| 330002188 | 330001230 | 1.8 | 62 | Not known (9) | 2014-06-07 | 2014-07-03 | Cisplatin 7 day | null | N | 330008193 | CISPLATIN |
| 330002189 | 330001231 | 1.59 | 45.5 | Palliative (P) | 2015-06-02 | 2015-06-09 | EW EuroEwing 2012 Arm B VDC | N | Y | 330008194 | TRIAL |
| 330002190 | 330001232 | null | 67.4 | Neo-adjuvant (N) | 2013-11-15 | 2013-11-27 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330008195 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002191 | 330001233 | 1.69 | 82.3 | Curative (C) | 2016-01-28 | 2016-02-10 | EW EuroEwing 2012 Arm A VAI | Y | N | 330008198 | TRIAL |
| 330002192 | 330001234 | null | 49.2 | Curative (C) | 2017-05-29 | 2017-06-03 | AML MyeChild 01 IT Cyt | Y | null | 330008199 | NOT MATCHED |
| 330002193 | 330001235 | 1.76 | 16.1 | Curative (C) | 2014-07-07 | 2014-07-22 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330008201 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002194 | 330001235 | 1.71 | null | Not known (9) | 2015-05-02 | 2015-05-29 | Cisplatin | N | Y | 330008201 | CISPLATIN |
| 330002195 | 330001235 | 1.63 | 15.3 | Palliative (P) | 2017-12-16 | 2017-12-16 | Trial Unspecified | N | N | 330008201 | TRIAL |
| 330002196 | 330001235 | 0 | 12.6 | Curative (C) | 2014-08-02 | 2014-08-04 | Trial Unspecified | Y | null | 330008201 | TRIAL |
| 330002197 | 330001236 | null | null | Curative (C) | 2016-12-01 | 2016-12-20 | Cisplatin 7 day | 01 | Y | 330008214 | CISPLATIN |
| 330002198 | 330001236 | 1.71 | null | Curative (C) | 2016-10-02 | 2016-10-24 | Cisplatin 7 day | 02 | N | 330008214 | CISPLATIN |
| 330002199 | 330001237 | 0 | 62.4 | Curative (C) | 2013-05-25 | 2013-08-03 | null | 02 | N | 330008219 | NOT MATCHED |
| 330002200 | 330001238 | 1.7 | 58.4 | Curative (C) | 2016-07-13 | 2016-08-08 | Cisplatin | N | Y | 330008221 | CISPLATIN |
| 330002201 | 330001239 | 1.6 | 6.9 | Neo-adjuvant (N) | 2017-12-28 | 2017-12-28 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330008231 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002202 | 330001240 | 1.36 | 89 | Curative (C) | null | 2016-08-09 | NB HRNBL-1 COJEC Ind COURSE B | N | Y | 330008233 | NOT MATCHED |
| 330002203 | 330001241 | null | null | Curative (C) | 2017-04-10 | 2017-04-15 | Trial Unspecified | 01 | N | 330008235 | TRIAL |
| 330002204 | 330001241 | 1.69 | 84 | null | 2016-12-24 | 2017-01-26 | Cisplatin | 02 | N | 330008235 | CISPLATIN |
| 330002205 | 330001241 | null | null | Unknown (U) | 2015-04-05 | 2015-04-14 | Cisplatin + Docetaxel +Fluorouracil | N | null | 330008235 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002206 | 330001241 | null | 92.05 | Neo-adjuvant (N) | 2015-09-26 | 2015-10-26 | Trial Unspecified | Y | N | 330008235 | TRIAL |
| 330002207 | 330001242 | null | 65 | Curative (C) | 2013-07-21 | 2013-07-21 | Cisplatin | N | Y | 330008242 | CISPLATIN |
| 330002208 | 330001243 | 1.82 | 53.8 | Curative (C) | 2014-05-05 | 2014-05-30 | Cisplatin 7 day | null | N | 330008245 | CISPLATIN |
| 330002209 | 330001244 | 1.71 | 37.4 | Curative (C) | null | 2016-08-04 | Cisplatin | N | Y | 330008252 | CISPLATIN |
| 330002210 | 330001245 | null | 20.3 | Curative (C) | 2016-04-04 | 2016-07-03 | WT SIOP 2002 01 post op Carbo, Etop | Y | N | 330008260 | NOT MATCHED |
| 330002211 | 330001246 | 0 | 58.2 | Curative (C) | 2015-12-07 | 2015-12-07 | STS Rhabdomyosarcoma RMS 2005 IVAVV | N | Y | 330008263 | NOT MATCHED |
| 330002212 | 330006661 | 1.63 | null | Curative (C) | 2014-06-16 | 2014-07-04 | Cisplatin | N | Y | 330008265 | CISPLATIN |
| 330002213 | 330006661 | 1.78 | 13 | Curative (C) | 2017-03-28 | 2017-04-17 | Cisplatin 7 day | null | Y | 330008265 | CISPLATIN |
| 330002214 | 330006661 | 1.77 | null | null | null | 2015-10-10 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330008265 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002217 | 330001248 | null | 71 | Curative (C) | null | 2013-10-21 | ALL Interfant 06 Ind d 1-7 Pred | Y | Y | 330008273 | NOT MATCHED |
| 330002218 | 330001248 | 1.62 | 89.8 | Curative (C) | 2017-09-22 | 2017-10-04 | Cisplatin | 01 | Y | 330008273 | CISPLATIN |
| 330002219 | 330001248 | null | 40.6 | Curative (C) | 2015-09-09 | 2015-09-15 | OST Euramos 1 Closed Trial - Ai | null | N | 330008273 | NOT MATCHED |
| 330002220 | 330001249 | 0 | 86 | Curative (C) | 2016-08-14 | 2016-08-15 | LCHIV SL-CT 6MP/MTX | Y | N | 330008284 | NOT MATCHED |
| 330002221 | 330001250 | 1.61 | 12 | null | 2016-07-24 | 2016-08-05 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 2 | N | 330008290 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002222 | 330001251 | 1.81 | 45 | null | 2016-01-17 | 2016-02-11 | Cisplatin 7 day | N | Y | 330008293 | CISPLATIN |
| 330002223 | 330001251 | 0 | 54.9 | Curative (C) | 2013-11-10 | 2013-11-21 | NB HRNBL-1 COJEC Ind COURSE A | Y | Y | 330008293 | NOT MATCHED |
| 330002226 | 330001253 | 1.71 | null | Neo-adjuvant (N) | null | 2015-02-10 | Cisplatin + Docetaxel +Fluorouracil | N | null | 330008299 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002227 | 330001254 | 1.66 | 65 | Neo-adjuvant (N) | 2015-01-24 | 2015-01-24 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 330008302 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002228 | 330001254 | 1.8 | null | Curative (C) | 2013-04-09 | 2013-04-14 | Cisplatin | 02 | Y | 330008302 | CISPLATIN |
| 330002229 | 330001254 | 1.8 | 61.5 | null | 2015-11-05 | 2015-11-12 | Trial Unspecified | Y | N | 330008302 | TRIAL |
| 330002230 | 330001254 | 1.72 | null | Neo-adjuvant (N) | null | 2016-04-09 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 330008302 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002231 | 330001255 | 1.74 | 57 | Neo-adjuvant (N) | 2016-07-31 | 2016-08-01 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330008309 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002234 | 330011211 | 1.79 | 98.8 | Disease modification (D) | 2014-08-23 | 2014-08-24 | Trial Unspecified | N | N | 330008316 | TRIAL |
| 330002235 | 330011211 | 1.74 | 54 | Curative (C) | 2014-01-26 | 2014-01-27 | EW EuroEwing 2012 Arm B VDC | 01 | N | 330008316 | TRIAL |
| 330002236 | 330001256 | 1.61 | 69.5 | Curative (C) | 2015-08-28 | 2015-09-21 | Cisplatin | N | Y | 330008319 | CISPLATIN |
| 330002237 | 330001257 | null | 75.5 | Neo-adjuvant (N) | null | 2016-10-28 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330008320 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002238 | 330006668 | 0 | 8.6 | Curative (C) | 2016-12-30 | 2016-12-31 | CISPLATIN + DACTINOMYCIN + ETOPOSIDE + FILGRASTIM + METHOTREXATE | 02 | N | 330008321 | NOT MATCHED |